-

Xevant White Paper Highlights Opportunities for Transparency in PBM Model, Introduces VerX as Breakthrough for Cost Optimization

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits analytics, today announced the release of a new white paper: “Cracking Open the PBM Black Box: Unlocking Transparency and Partnership with VerX.” The report explores the challenges faced by traditional pharmacy benefit manager (PBM) models and highlights how VerX is helping plan sponsors and PBMs align around data-driven insights to improve cost management and Performance.

Evolving Challenges in the PBM Model

The white paper notes that while PBMs play a critical role in managing prescription drug benefits, longstanding complexities in pricing, rebate flows, and contract structures can make it difficult for plan sponsors to fully understand the true net cost of medications.

Among the common challenges:

  • Limited access to real-time data that hinders proactive decision-making
  • Complex pricing structures across retail, mail, and specialty channels
  • Formulary alignment that may not always maximize value for patients and payers

Without timely insights, opportunities for optimization often remain undiscovered until renewal periods.

How VerX Supports Smarter Pharmacy Benefits

Xevant’s VerX platform provides the real-time visibility and intelligence needed to close these gaps and foster collaboration between PBMs, employers, and brokers. By delivering claim-level transparency and actionable insights, VerX enables stakeholders to identify opportunities and take action sooner.

Key features include:

  • Claim-level cost analysis in real time
  • Predictive modeling to evaluate benefit design or formulary changes
  • Mid-contract flexibility to implement improvements without waiting for renewal
  • 15–25% average savings, with some clients achieving up to 31%

A New Era of Collaboration

“For too long, pharmacy benefits have been managed with limited visibility,” said Brandon Newman, CEO of Xevant. “With VerX, we’re helping plan sponsors and PBMs work together more effectively. Real-time insights give both parties the ability to improve performance, reduce waste, and ensure benefits deliver the value they’re designed to provide.”

Download the White Paper

The full white paper is available at www.xevant.com/verx-cracks-pbm-black-box.com. To explore how VerX can enhance your pharmacy benefits strategy, visit www.xevant.com or contact the Xevant team at sales@xevant.com, 888.774.5551.

About Xevant

Xevant is a leading provider of real-time pharmacy benefits intelligence, helping employers, brokers, and payers gain visibility into true drug costs and unlock measurable savings. Its VerX platform delivers claim-level insights, formulary optimization, and rebate performance tracking—empowering smarter decisions and faster action across the pharmacy benefit lifecycle. With a focus on transparency, collaboration, and measurable impact, Xevant is redefining how pharmacy benefits are managed in today’s complex healthcare environment. Learn more at www.xevant.com.

Contacts

Rachel Moore
Society22 PR
929.367.8993
xevant@society22pr.com

Xevant


Release Versions

Contacts

Rachel Moore
Society22 PR
929.367.8993
xevant@society22pr.com

More News From Xevant

Xevant Expands Ivim at Work and Introduces New Lower Pricing on Wegovy® and Ozempic® for Employers Nationwide

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced expanded access to new, lower pricing for its employer-focused medical weight-loss program, Ivim at Work, significantly reducing the cost of GLP-1 therapy for self-funded employers, brokers, and PBMs. The enhanced pricing structure is fully optimized through Xevant’s VerX platform, which identifies and delivers the lowest-cost, clinically appropriate options across the pharmacy ecosystem. The update introduces pricing starting at $199 per mont...

Xevant Expands VerX Platform, Delivering AI-Driven Pharmacy Cost Optimization in the Emerging RxTech Era

LEHI, Utah--(BUSINESS WIRE)--Xevant today announced major advances to its VerX™ Platform, unveiling a new set of interconnected systems — Cortex, Pulse, Axis, and Nudge — that together demonstrate the operational reality of RxTech, the emerging technology segment transforming pharmacy benefits to eliminate more than $250 billion in prescription waste and deliver the lowest net cost for medications. Following VerX’s initial debut earlier this summer, Xevant now shows how its AI-driven platform d...

Xevant Releases New eBook Uncovering the Top 4 PBM Trends Reshaping Pharmacy Benefits in 2025

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in AI-driven pharmacy benefits optimization, today announced the release of its latest eBook: Top 4 PBM Trends to Watch in 2025 and Beyond. The publication explores four critical trends that are transforming the pharmacy benefits landscape and offers timely strategies for pharmacy benefit managers, brokers, benefits consultants, health plan executives, TPAs, and self-insured employers. The free eBook is available for download at: https://www.xevant....
Back to Newsroom